by EmpathiCSubstanceS | May 28, 2018 | Anxiety
Most people know Michael Pollan as a food writer. His 2006 book, The Omnivore’s Dilemma, is widely credited with helping spark the modern food movement, in which everyday Americans began asking questions about where their food comes from. But in his new book,...
by EmpathiCSubstanceS | May 14, 2018 | Anxiety
Sabrina Misra suffered from depression for most of her life, but last summer, it became almost too heavy to bear. Despite years of therapy and a trove of medications, Misra, 36, had become so despondent that she started planning her suicide. But before she acted, her...
by EmpathiCSubstanceS | May 14, 2018 | Anxiety, Depression
If we’re going to use psychedelics for therapy, we’re going to have to figure out the proverbial bad trip. This story is part of When the Drugs Hit, a Motherboard journey into the science, politics, and culture of today’s psychedelic renaissance. Follow along...
by EmpathiCSubstanceS | May 2, 2018 | Anxiety
phosphorloxy-N,N-dimethyltryptamine (psilocybin) and methylenedioxymethamfetamine (MDMA), best known for their illegal use as psychedelic drugs, are showing promise as therapeutics in a resurgence of clinical research during the past 10 years. Psilocybin is being...
by EmpathiCSubstanceS | May 2, 2018 | Addiction, Anxiety
It hurts to be left out, but for most people, social exclusion doesn’t become pathological. For people with depression, anxiety or other mental health issues, though, it can be a huge problem, worsening symptoms and creating a feedback loop of negativity. Enter...
by EmpathiCSubstanceS | May 2, 2018 | Anxiety, Depression
Researchers’ long fight to test psilocybin’s safety finally yields fruit. A hallucinogenic drug derived from magic mushrooms could be useful in treating depression, the first safety study of this approach has concluded. Researchers from Imperial College...
